Lv3
250 积分 2024-09-05 加入
Treatment of pemphigus foliaceus with upadacitinib
4天前
已完结
Predictive Factors for Long-Term High Responders to Upadacitinib Treatment in Patients with Atopic Dermatitis
4天前
已完结
Predictive Factors for Primary and Secondary Nonresponders to Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Study
4天前
求助中
Comment on “A Practical Guide to Using Oral JAK Inhibitors for Atopic Dermatitis from the International Eczema Council”- A case of Rhabdomyolysis Induced by Upadacitinib
4天前
已完结
Upadacitinib outperforms dupilumab in restoring the fungal microbiome in atopic dermatitis
4天前
已完结
Nuevas Fronteras en el Tratamiento de la Dermatitis de Contacto Alérgica: El Rol de las Terapias Emergentes
4天前
已完结
Use of upadacitinib in managing multiresistant atopic dermatitis
4天前
已完结
Switching from dupilumab to tralokinumab or Janus kinase inhibitors in cases of ocular and/or facial adverse events in patients with atopic dermatitis: a multicenter retrospective study
4天前
已完结
Differences in clinical characteristics and lesion proteomics between inflammatory linear verrucous epidermal nevus and local verrucous epidermal nevus
10天前
已完结
A case of inflammatory linear verrucous epidermal nevus successfully treated with Brodalumab
10天前
已完结
皖公网安备34019202002308
